China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Down 46.3% in October

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the recipient of a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 105,300 shares, a decline of 46.3% from the October 15th total of 196,000 shares. Currently, 3.1% of the company’s shares are sold short. Based on an average trading volume of 614,600 shares, the short-interest ratio is presently 0.2 days.

China SXT Pharmaceuticals Stock Performance

SXTC traded down $0.01 during trading on Wednesday, reaching $0.46. 7,353 shares of the company’s stock were exchanged, compared to its average volume of 745,761. The company’s fifty day moving average price is $0.61 and its 200-day moving average price is $0.89. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.60 and a quick ratio of 1.51. China SXT Pharmaceuticals has a fifty-two week low of $0.43 and a fifty-two week high of $6.39.

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.